Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
II Robert C. Goeltz currently holds 96,000 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, II Robert C. Goeltz has been a net seller of CTMX stock. They have purchased $107.8K and sold $1.2M worth of shares.
II Robert C. Goeltz's most recent insider trade was on Jan 23, 2026, when they sold 96,000 shares at $0.00 per share.
II Robert C. Goeltz serves as Executive at CytomX Therapeutics, Inc. (CTMX). They have executed 41 insider transactions totaling $1.3M over their tenure at the company.
II Robert C. Goeltz holds the position of Executive at CytomX Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
II Robert C. Goeltz has shown a selling trading pattern, with $107.8K in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by II Robert C. Goeltz was on Mar 20, 2017, when they sold $230.3K worth of CTMX shares. This transaction involved 11,517 shares at $20.00 per share.
II Robert C. Goeltz currently owns 96,000 shares of CytomX Therapeutics, Inc. (CTMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of II Robert C. Goeltz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. II Robert C. Goeltz has 41 Form 4 filings on record as an insider at CytomX Therapeutics, Inc..
Set alerts for II Robert C. Goeltz and 40,000+ other insiders.